Celsius stock bet yields €15,000 profit from all-in wager

€50,000 all-in on Celsius: From -$461 to €15,000 profit

Putting €50,000—his entire savings—into a single energy drink stock is reckless, yet in this specific case, it has paid off so far. The author of the bet announced it plainly: he liquidated his investment funds, bought 1,591 shares of Celsius Holdings at $31.92, and warned he wouldn't sell them "until they triple or I go bust." According to his own calculations, that position accumulated about €15,000 in profit. For now, the picture is one of extreme risk still alive.

That such a move works once doesn't make it a strategy, and the path had more warnings than applause. The story matters because it summarizes the eternal clash between those who bet everything on one card and those who diversify out of prudence.

What is Celsius and why the purchase raised doubts

Celsius Holdings is the company behind a well-known energy drink brand, a sector that has attracted capital and, with it, volatility in recent years. The initial reaction to the purchase was a mix of mockery and pity: it was remembered that you should never put all your money in the same place, and most agreed there were less reckless options. Specific alternatives were cited: Mapfre, with a dividend above 5% and growing premiums; Catalana Occidente as an insurance alternative; or directly gold, given antiestéticars of a correction while indices are at historic highs.

None of these proposals were, in themselves, absurd; none promised, however, the jackpot sought by the thread's author.

The journey: from -$461 to a 50% rise

The debut was bad. The day after buying, the account showed -461 dollars, seemingly confirming the worst predictions. "My madness starts badly," the investor seemed to say, with the resignation of someone who has already accepted the risk. And yet, he pushed forward.

Afterwards, Celsius touched $46, a 50% increase over the reference price. Optimism spread: trading volumes tripled the average, and some saw institutional money entering the stock. Others, with the same information, warned that this could also be the precursor to a fall, and that a correction below $30 wasn't impossible before any serious takeoff.

Call options and the business of rolling

Here is the technical part worth understanding. To squeeze extra value from the shares without selling them, they began launching calls—buy options sold against their own position—with the intention of pocketing the premium. The problem is known: if the stock rises above the agreed price, at expiration you must release the titles or buy back the option at a higher cost.

The solution was continuous rolling. Another forum user with a position in Celsius detailed his sequence: first a call at $47.5 expiring in September; then, with the stock already at $55, jumping to a $55 call for September 2026 and later to a $60 call for January 2027. The thread's author himself confirmed he was still "rolling positions" to avoid letting go of the shares. The details of how each position was closed and at what price are left for those trinc closely, because that is where the difference lies between winning and missing the rally.

The destination of the money: a high-yield ETF

With the shares intact and premiums accumulating, the plan changed its objective. It was no longer just about tripling, but about reinvesting the income from options into a high-yield ETF, with an explicit goal: to gather €30,000 in that product to obtain a "monthly salary" of about €1,500. The interested party himself acknowledges the risk—if it goes wrong, he would lose what he earned with the premiums—although here lies the trap: that "nothing else" assumes the main stock never hits back.

The alternatives left by the wayside

The chorus of warnings didn't stop. The case of someone who put €100,000 into Intel just before the crash was recalled, and according to accounts, he hasn't slept well since. Other corners of the market with recent rallies were listed—quantum computing, artificial intelligence—with dizzying returns in months and the logical warning to be careful when entering. And emphasis was placed on diversifying: never everything in one place, better to spread across punished sectors with room to grow.

In parallel, the one betting everything on one card counted his own nerves: he considered changing companies and looking for "the jackpot of my life," and confessed to being in a serious dilemma before deciding with a cool head. In the end, he didn't. He stayed and rolled positions.

Today the bet is still alive and in the green, but it is not closed: as long as the last call hasn't expired, the result is a snapshot, not a settlement. If Celsius holds steady and the rolls hold up, the experiment will pass into the annals of "I told you so." If the stock turns around before January 2027, the same person who today boasts of his nose will again hear that it wasn't an investment, but a gamble. For now, recklessness is beating prudence. Time will tell.